Peak Heart and Vascular Revenue and Competitors

Surprise, AZ USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Peak Heart and Vascular's estimated annual revenue is currently $1.7M per year.(i)
  • Peak Heart and Vascular's estimated revenue per employee is $80,952

Employee Data

  • Peak Heart and Vascular has 21 Employees.(i)
  • Peak Heart and Vascular grew their employee count by 17% last year.

Peak Heart and Vascular's People

NameTitleEmail/Phone
1
Office ManagerReveal Email/Phone
2
Medical BillerReveal Email/Phone
3
Vascular SurgeonReveal Email/Phone
4
Billing SpecialistReveal Email/Phone
5
Vascular SurgeonReveal Email/Phone
6
Interventional CardiologistReveal Email/Phone
7
Physician LiaisonReveal Email/Phone
8
Interventional CardiologistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M2117%N/AN/A
#2
N/A3431%N/AN/A
#3
$3.5M26921%N/AN/A
#4
N/A120%N/AN/A
#5
N/A7023%N/AN/A
#6
N/A29024%N/AN/A
#7
N/A3036%N/AN/A
#8
N/A3088%N/AN/A
Add Company

What Is Peak Heart and Vascular?

keywords:N/A

N/A

Total Funding

21

Number of Employees

$1.7M

Revenue (est)

17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Peak Heart and Vascular News

2022-04-20 - Racing must enter the 21st Century and embrace data

Think how fascinating it would be to compare the peak heart rate and rates of recovery of the first four horses home in the Derby.

2022-04-17 - Covid was the third leading cause of death in the U.S. last year, with only heart disease and cancer killing more

Only heart disease and cancer killed more people than Covid in 2021, ... Though deaths from Covid have dropped 85% from the peak of the...

2022-03-30 - Merck looks to cardiovascular pipeline for $10B-plus peak ...

A phase 3 trial testing the therapy in patients with chronic heart failure and reduced ejection fraction is estimated to complete in early 2025.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.9M24-37%N/A
#2
$4.6M29-9%N/A
#3
$4.6M294%N/A
#4
$3.5M30-6%N/A
#5
$4.3M307%N/A